Literature DB >> 16338395

Ubiquitin fusion technique and related methods.

Alexander Varshavsky1.   

Abstract

The ubiquitin fusion technique, developed in 1986, is still the method of choice for producing a desired N-terminal residue in a protein of interest in vivo. This technique is also used as a tool for protein expression. Over the past two decades, several otherwise unrelated methods were invented that have in common the use of ubiquitin fusions as a component of design. I describe the original ubiquitin fusion technique, its current applications, and other methods that use the properties of ubiquitin fusions.

Mesh:

Substances:

Year:  2005        PMID: 16338395     DOI: 10.1016/S0076-6879(05)99051-4

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  57 in total

1.  Liat1, an arginyltransferase-binding protein whose evolution among primates involved changes in the numbers of its 10-residue repeats.

Authors:  Christopher S Brower; Connor E Rosen; Richard H Jones; Brandon C Wadas; Konstantin I Piatkov; Alexander Varshavsky
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-04       Impact factor: 11.205

2.  The C-terminal proteolytic fragment of the breast cancer susceptibility type 1 protein (BRCA1) is degraded by the N-end rule pathway.

Authors:  Zhizhong Xu; Roshani Payoe; Richard P Fahlman
Journal:  J Biol Chem       Date:  2012-01-18       Impact factor: 5.157

3.  The N-end rule pathway counteracts cell death by destroying proapoptotic protein fragments.

Authors:  Konstantin I Piatkov; Christopher S Brower; Alexander Varshavsky
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-05       Impact factor: 11.205

4.  Differential N-end Rule Degradation of RIN4/NOI Fragments Generated by the AvrRpt2 Effector Protease.

Authors:  Kevin Goslin; Lennart Eschen-Lippold; Christin Naumann; Eric Linster; Maud Sorel; Maria Klecker; Rémi de Marchi; Anne Kind; Markus Wirtz; Justin Lee; Nico Dissmeyer; Emmanuelle Graciet
Journal:  Plant Physiol       Date:  2019-06-21       Impact factor: 8.340

5.  In vivo modeling of polysumoylation uncovers targeting of Topoisomerase II to the nucleolus via optimal level of SUMO modification.

Authors:  Yoshimitsu Takahashi; Alexander Strunnikov
Journal:  Chromosoma       Date:  2007-11-29       Impact factor: 4.316

6.  Aminoacyl-transferases and the N-end rule pathway of prokaryotic/eukaryotic specificity in a human pathogen.

Authors:  Emmanuelle Graciet; Rong-Gui Hu; Konstantin Piatkov; Joon Haeng Rhee; Erich M Schwarz; Alexander Varshavsky
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

7.  Discovery of cellular regulation by protein degradation.

Authors:  Alexander Varshavsky
Journal:  J Biol Chem       Date:  2008-08-15       Impact factor: 5.157

8.  PINK1 is degraded through the N-end rule pathway.

Authors:  Koji Yamano; Richard J Youle
Journal:  Autophagy       Date:  2013-04-17       Impact factor: 16.016

9.  Neurodegeneration-associated protein fragments as short-lived substrates of the N-end rule pathway.

Authors:  Christopher S Brower; Konstantin I Piatkov; Alexander Varshavsky
Journal:  Mol Cell       Date:  2013-03-14       Impact factor: 17.970

10.  Substrate-binding sites of UBR1, the ubiquitin ligase of the N-end rule pathway.

Authors:  Zanxian Xia; Ailsa Webster; Fangyong Du; Konstantin Piatkov; Michel Ghislain; Alexander Varshavsky
Journal:  J Biol Chem       Date:  2008-06-19       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.